What Is Peripheral Artery Disease (PAD)
Peripheral Artery Disease (PAD)
Peripheral artery disease (PAD) is a highly prevalent condition in which arteries outside of the heart become narrowed or blocked due to a build up of plaque. Affecting more than 9 million people in the U.S., and 200 million people worldwide, PAD’s primary risk factors include obesity, hypertension, diabetes and tobacco use. Many medical devices have been developed in recent decades to treat PAD, and the most often used treatments include angioplasty, stenting, and paclitaxel-coated devices.
Despite these advances, an unmet need still exists for the treatment of PAD. A number of studies have shown that balloon angioplasty and stenting have a failure rate of 50 to 70 percent at two years in patients with PAD. This is especially true in the case of calcified or long lesions as well as those treatments complicated by arterial dissection.
Alucent Biomedical was founded to address this unmet need with its Natural Vascular Scaffolding™ (NVS) therapy.
million people in US affected by PAD
million people worldwide affected by PAD